New and Novel Agents for Advanced Bladder Cancer.

Authors

Michael Superdock, Gopa Iyer, Matthew I Milowsky

Published in

The Urologic clinics of North America. Volume 53. Issue 4. Pages 635-648. Epub Jul 23, 2026.

Abstract

Treatment for advanced bladder cancer is rapidly evolving after decades of limited progress. Antibody-drug conjugates, targeted therapies, novel immunotherapy strategies, and innovative delivery platforms are reshaping management of both metastatic and muscle-invasive disease. This article focuses on promising new and novel agents, many of which are not yet standard of care, emphasizing their biological rationale and key clinical trial data to provide a forward-looking perspective on the future of bladder cancer management.

PMID:
42823054
Bibliographic data and abstract were imported from PubMed on 02 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.